JOHNSON KENNETH ERLAND (See Remarks) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Common Stock
Shares
+11.25K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+78.33K
Price / share
—
Trade value
—
% of position
Net shares
+89.58K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/5/2021 | A · Award | +11.25K | — | — | New position | 0.00 | 11.25K |
| Common Stock Direct | 10/5/2021 | A · Award | +78.33K | — | — | 696.3% | 11.25K | 89.58K |
| Total | +89.58K | $0.00 | ||||||
Stock Option (Right to Buy)
Common Stock
33.69K shares
Shares
+33.69K
Strike price
1.55
Held after
33.69K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
5.28K shares
Shares
+5.28K
Strike price
1.55
Held after
5.28K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
39.63K shares
Shares
+39.63K
Strike price
5.93
Held after
39.63K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
21.40K shares
Shares
+21.40K
Strike price
19.00
Held after
21.40K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
32.50K shares
Shares
+32.50K
Strike price
13.88
Held after
32.50K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
100K shares
Shares
+100K
Strike price
3.94
Held after
100K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock33.69K shares | 10/5/2021 | A · Award | +33.69K | 1.55 | — | 33.69K |
| Stock Option (Right to Buy) Direct | Common Stock5.28K shares | 10/5/2021 | A · Award | +5.28K | 1.55 | — | 5.28K |
| Stock Option (Right to Buy) Direct | Common Stock39.63K shares | 10/5/2021 | A · Award | +39.63K | 5.93 | — | 39.63K |
| Stock Option (Right to Buy) Direct | Common Stock21.40K shares | 10/5/2021 | A · Award | +21.40K | 19.00 | — | 21.40K |
| Stock Option (Right to Buy) Direct | Common Stock32.50K shares | 10/5/2021 | A · Award | +32.50K | 13.88 | — | 32.50K |
| Stock Option (Right to Buy) Direct | Common Stock100K shares | 10/5/2021 | A · Award | +100K | 3.94 | — | 100K |